nodes	percent_of_prediction	percent_of_DWPC	metapath
Dobutamine—COMT—blood plasma—acquired immunodeficiency syndrome	0.0291	0.0886	CbGeAlD
Dobutamine—Skin exfoliation—Nevirapine—acquired immunodeficiency syndrome	0.0271	0.0403	CcSEcCtD
Dobutamine—Phlebitis—Zidovudine—acquired immunodeficiency syndrome	0.0201	0.0299	CcSEcCtD
Dobutamine—Skin exfoliation—Efavirenz—acquired immunodeficiency syndrome	0.02	0.0298	CcSEcCtD
Dobutamine—Skin exfoliation—Delavirdine—acquired immunodeficiency syndrome	0.0191	0.0285	CcSEcCtD
Dobutamine—CA2—blood plasma—acquired immunodeficiency syndrome	0.0181	0.0551	CbGeAlD
Dobutamine—Phlebitis—Ritonavir—acquired immunodeficiency syndrome	0.0156	0.0232	CcSEcCtD
Dobutamine—Phlebitis—Lamivudine—acquired immunodeficiency syndrome	0.0143	0.0213	CcSEcCtD
Dobutamine—COMT—skin of body—acquired immunodeficiency syndrome	0.014	0.0426	CbGeAlD
Dobutamine—Hypokalaemia—Efavirenz—acquired immunodeficiency syndrome	0.0138	0.0206	CcSEcCtD
Dobutamine—Angina pectoris—Indinavir—acquired immunodeficiency syndrome	0.0135	0.0202	CcSEcCtD
Dobutamine—Hypokalaemia—Saquinavir—acquired immunodeficiency syndrome	0.0118	0.0175	CcSEcCtD
Dobutamine—CA5B—blood—acquired immunodeficiency syndrome	0.0116	0.0352	CbGeAlD
Dobutamine—COMT—digestive system—acquired immunodeficiency syndrome	0.0112	0.0341	CbGeAlD
Dobutamine—Thrombocytopenia—Didanosine—acquired immunodeficiency syndrome	0.011	0.0164	CcSEcCtD
Dobutamine—CA5B—vagina—acquired immunodeficiency syndrome	0.0107	0.0327	CbGeAlD
Dobutamine—COMT—blood—acquired immunodeficiency syndrome	0.0107	0.0325	CbGeAlD
Dobutamine—COMT—bone marrow—acquired immunodeficiency syndrome	0.0103	0.0314	CbGeAlD
Dobutamine—COMT—spinal cord—acquired immunodeficiency syndrome	0.0103	0.0313	CbGeAlD
Dobutamine—CA5B—lung—acquired immunodeficiency syndrome	0.0102	0.0309	CbGeAlD
Dobutamine—Thrombocytopenia—Nevirapine—acquired immunodeficiency syndrome	0.00991	0.0148	CcSEcCtD
Dobutamine—CA2—retina—acquired immunodeficiency syndrome	0.00991	0.0302	CbGeAlD
Dobutamine—COMT—vagina—acquired immunodeficiency syndrome	0.00989	0.0301	CbGeAlD
Dobutamine—Thrombocytopenia—Nelfinavir—acquired immunodeficiency syndrome	0.0096	0.0143	CcSEcCtD
Dobutamine—Thrombocytopenia—Stavudine—acquired immunodeficiency syndrome	0.00957	0.0143	CcSEcCtD
Dobutamine—Thrombocytopenia—Abacavir—acquired immunodeficiency syndrome	0.00943	0.014	CcSEcCtD
Dobutamine—CA5B—nervous system—acquired immunodeficiency syndrome	0.0094	0.0286	CbGeAlD
Dobutamine—COMT—lung—acquired immunodeficiency syndrome	0.00935	0.0285	CbGeAlD
Dobutamine—CA5B—central nervous system—acquired immunodeficiency syndrome	0.00905	0.0276	CbGeAlD
Dobutamine—Hypotension—Abacavir—acquired immunodeficiency syndrome	0.009	0.0134	CcSEcCtD
Dobutamine—Chest pain—Zidovudine—acquired immunodeficiency syndrome	0.00886	0.0132	CcSEcCtD
Dobutamine—Dyspnoea—Nelfinavir—acquired immunodeficiency syndrome	0.00874	0.013	CcSEcCtD
Dobutamine—Pruritus—Amprenavir—acquired immunodeficiency syndrome	0.00874	0.013	CcSEcCtD
Dobutamine—CA2—skin of body—acquired immunodeficiency syndrome	0.0087	0.0265	CbGeAlD
Dobutamine—COMT—nervous system—acquired immunodeficiency syndrome	0.00866	0.0264	CbGeAlD
Dobutamine—Dyspnoea—Abacavir—acquired immunodeficiency syndrome	0.00858	0.0128	CcSEcCtD
Dobutamine—Palpitations—Indinavir—acquired immunodeficiency syndrome	0.00855	0.0127	CcSEcCtD
Dobutamine—COMT—central nervous system—acquired immunodeficiency syndrome	0.00834	0.0254	CbGeAlD
Dobutamine—Thrombocytopenia—Zidovudine—acquired immunodeficiency syndrome	0.00832	0.0124	CcSEcCtD
Dobutamine—Chest pain—Indinavir—acquired immunodeficiency syndrome	0.00824	0.0123	CcSEcCtD
Dobutamine—Palpitations—Efavirenz—acquired immunodeficiency syndrome	0.00808	0.012	CcSEcCtD
Dobutamine—Pruritus—Didanosine—acquired immunodeficiency syndrome	0.00796	0.0119	CcSEcCtD
Dobutamine—ADRB1—lung—acquired immunodeficiency syndrome	0.00792	0.0241	CbGeAlD
Dobutamine—Chest pain—Efavirenz—acquired immunodeficiency syndrome	0.00779	0.0116	CcSEcCtD
Dobutamine—Headache—Amprenavir—acquired immunodeficiency syndrome	0.00774	0.0115	CcSEcCtD
Dobutamine—Thrombocytopenia—Indinavir—acquired immunodeficiency syndrome	0.00774	0.0115	CcSEcCtD
Dobutamine—Palpitations—Delavirdine—acquired immunodeficiency syndrome	0.00773	0.0115	CcSEcCtD
Dobutamine—Dyspnoea—Zidovudine—acquired immunodeficiency syndrome	0.00757	0.0113	CcSEcCtD
Dobutamine—Chest pain—Delavirdine—acquired immunodeficiency syndrome	0.00745	0.0111	CcSEcCtD
Dobutamine—ADRB1—nervous system—acquired immunodeficiency syndrome	0.00734	0.0223	CbGeAlD
Dobutamine—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.00734	0.0109	CcSEcCtD
Dobutamine—Thrombocytopenia—Efavirenz—acquired immunodeficiency syndrome	0.00731	0.0109	CcSEcCtD
Dobutamine—Tachycardia—Efavirenz—acquired immunodeficiency syndrome	0.00729	0.0109	CcSEcCtD
Dobutamine—CA5B—brain—acquired immunodeficiency syndrome	0.00719	0.0219	CbGeAlD
Dobutamine—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.00716	0.0107	CcSEcCtD
Dobutamine—Palpitations—Ritonavir—acquired immunodeficiency syndrome	0.00715	0.0107	CcSEcCtD
Dobutamine—ADRB1—central nervous system—acquired immunodeficiency syndrome	0.00706	0.0215	CbGeAlD
Dobutamine—Headache—Didanosine—acquired immunodeficiency syndrome	0.00705	0.0105	CcSEcCtD
Dobutamine—CA2—lymphoid tissue—acquired immunodeficiency syndrome	0.00705	0.0214	CbGeAlD
Dobutamine—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.00704	0.0105	CcSEcCtD
Dobutamine—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.00699	0.0104	CcSEcCtD
Dobutamine—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.00697	0.0104	CcSEcCtD
Dobutamine—CA2—digestive system—acquired immunodeficiency syndrome	0.00696	0.0212	CbGeAlD
Dobutamine—CA5B—lymph node—acquired immunodeficiency syndrome	0.00695	0.0211	CbGeAlD
Dobutamine—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.00694	0.0103	CcSEcCtD
Dobutamine—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.00691	0.0103	CcSEcCtD
Dobutamine—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.00689	0.0103	CcSEcCtD
Dobutamine—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.00681	0.0101	CcSEcCtD
Dobutamine—Nausea—Didanosine—acquired immunodeficiency syndrome	0.00669	0.00996	CcSEcCtD
Dobutamine—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.00667	0.00994	CcSEcCtD
Dobutamine—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.00665	0.00991	CcSEcCtD
Dobutamine—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.00663	0.00988	CcSEcCtD
Dobutamine—CA2—blood—acquired immunodeficiency syndrome	0.00663	0.0202	CbGeAlD
Dobutamine—COMT—brain—acquired immunodeficiency syndrome	0.00662	0.0201	CbGeAlD
Dobutamine—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.00647	0.00963	CcSEcCtD
Dobutamine—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.00645	0.0096	CcSEcCtD
Dobutamine—CA2—bone marrow—acquired immunodeficiency syndrome	0.00642	0.0195	CbGeAlD
Dobutamine—COMT—lymph node—acquired immunodeficiency syndrome	0.0064	0.0195	CbGeAlD
Dobutamine—CA2—spinal cord—acquired immunodeficiency syndrome	0.00639	0.0194	CbGeAlD
Dobutamine—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.00637	0.00948	CcSEcCtD
Dobutamine—Headache—Nevirapine—acquired immunodeficiency syndrome	0.00634	0.00945	CcSEcCtD
Dobutamine—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.00633	0.00942	CcSEcCtD
Dobutamine—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.00622	0.00927	CcSEcCtD
Dobutamine—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.00617	0.00919	CcSEcCtD
Dobutamine—CA2—vagina—acquired immunodeficiency syndrome	0.00615	0.0187	CbGeAlD
Dobutamine—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.00614	0.00915	CcSEcCtD
Dobutamine—Headache—Stavudine—acquired immunodeficiency syndrome	0.00612	0.00912	CcSEcCtD
Dobutamine—Headache—Abacavir—acquired immunodeficiency syndrome	0.00603	0.00898	CcSEcCtD
Dobutamine—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.00601	0.00896	CcSEcCtD
Dobutamine—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.00601	0.00895	CcSEcCtD
Dobutamine—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.00594	0.00885	CcSEcCtD
Dobutamine—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.00594	0.00884	CcSEcCtD
Dobutamine—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.00589	0.00877	CcSEcCtD
Dobutamine—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.00582	0.00867	CcSEcCtD
Dobutamine—CA2—lung—acquired immunodeficiency syndrome	0.00581	0.0177	CbGeAlD
Dobutamine—Nausea—Stavudine—acquired immunodeficiency syndrome	0.00581	0.00865	CcSEcCtD
Dobutamine—Nausea—Abacavir—acquired immunodeficiency syndrome	0.00572	0.00852	CcSEcCtD
Dobutamine—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.00567	0.00844	CcSEcCtD
Dobutamine—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.00567	0.00844	CcSEcCtD
Dobutamine—ADRB1—brain—acquired immunodeficiency syndrome	0.00561	0.0171	CbGeAlD
Dobutamine—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.00559	0.00833	CcSEcCtD
Dobutamine—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.00541	0.00805	CcSEcCtD
Dobutamine—CA2—nervous system—acquired immunodeficiency syndrome	0.00538	0.0164	CbGeAlD
Dobutamine—Headache—Zidovudine—acquired immunodeficiency syndrome	0.00532	0.00793	CcSEcCtD
Dobutamine—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.00528	0.00787	CcSEcCtD
Dobutamine—CA2—central nervous system—acquired immunodeficiency syndrome	0.00518	0.0158	CbGeAlD
Dobutamine—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.00505	0.00753	CcSEcCtD
Dobutamine—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.00505	0.00752	CcSEcCtD
Dobutamine—Headache—Indinavir—acquired immunodeficiency syndrome	0.00495	0.00737	CcSEcCtD
Dobutamine—Nausea—Indinavir—acquired immunodeficiency syndrome	0.00469	0.00699	CcSEcCtD
Dobutamine—Headache—Efavirenz—acquired immunodeficiency syndrome	0.00468	0.00697	CcSEcCtD
Dobutamine—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.00467	0.00696	CcSEcCtD
Dobutamine—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.0045	0.0067	CcSEcCtD
Dobutamine—Headache—Delavirdine—acquired immunodeficiency syndrome	0.00447	0.00666	CcSEcCtD
Dobutamine—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.00443	0.0066	CcSEcCtD
Dobutamine—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.00429	0.00639	CcSEcCtD
Dobutamine—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.00424	0.00632	CcSEcCtD
Dobutamine—Headache—Ritonavir—acquired immunodeficiency syndrome	0.00414	0.00616	CcSEcCtD
Dobutamine—CA2—brain—acquired immunodeficiency syndrome	0.00411	0.0125	CbGeAlD
Dobutamine—Headache—Saquinavir—acquired immunodeficiency syndrome	0.00398	0.00593	CcSEcCtD
Dobutamine—CA2—lymph node—acquired immunodeficiency syndrome	0.00398	0.0121	CbGeAlD
Dobutamine—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.00392	0.00584	CcSEcCtD
Dobutamine—Headache—Lamivudine—acquired immunodeficiency syndrome	0.0038	0.00566	CcSEcCtD
Dobutamine—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.00378	0.00562	CcSEcCtD
Dobutamine—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.0036	0.00537	CcSEcCtD
